Literature DB >> 17000085

Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.

Selçuk Yüksel1, Burcu Oztürk, Asli Kavaz, Z Birsin Ozçakar, Banu Acar, Haluk Güriz, Derya Aysev, Mesiha Ekim, Fatoş Yalçinkaya.   

Abstract

The changing pattern of antimicrobial resistance in the causative microorganisms of urinary tract infection (UTI) in childhood is a growing problem. The aims of this study were to assess the resistance patterns of urinary isolates to commonly used antimicrobials and to evaluate the options for empirical treatment of UTI. A prospective cross-sectional analysis of bacteria isolated from children with UTI was performed between January 2003 and January 2004. Resistance to antibiotics was analysed in three age groups: Group I, < or =12 months; Group II, 13-60 months; and Group III, >60 months. A total of 165 urinary pathogens were isolated from 131 patients. Mean patient age was 63.7+/-49.8 months. The most common causative agent was Escherichia coli (87% of cases) followed by Klebsiella pneumoniae (10%). Resistance to ampicillin (74.2%) and co-trimoxazole (61.3%) was significant in all isolates. Nitrofurantoin was the most active agent against E. coli (2.2% resistant isolates), followed by amikacin (4.9%), ceftriaxone (7.5%) and ciprofloxacin (12%). None of the isolates from Group I patients were resistant to ciprofloxacin and a low resistance rate (7.1%) was noted for amikacin. In Group II patients, none of the isolates were resistant to amikacin, and ceftriaxone was the second most suitable antibiotic (resistance rate 2.2%). In Group III patients, the lowest resistance rate was against nitrofurantoin (2.7%). In conclusion, we observed that the use of ampicillin and co-trimoxazole as a single agent for empirical treatment of a suspected UTI would not cover the majority of urinary pathogens in our region. Whilst amikacin, with a negligible resistance rate, was suitable in all age groups, gentamicin might still be useful as an empirical treatment of UTI in children aged >1 year. Nitrofurantoin could be included as a reasonable alternative in the empirical treatment of lower UTI in older children.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000085     DOI: 10.1016/j.ijantimicag.2006.08.009

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  27 in total

1.  Resistance against broad-spectrum beta-lactams among uropathogens in children.

Authors:  Maria Bitsori; Sofia Maraki; Maria Kalmanti; Emmanouil Galanakis
Journal:  Pediatr Nephrol       Date:  2009-07-28       Impact factor: 3.714

2.  Antimicrobial susceptibility of pediatric uropathogens in Thrace, Greece.

Authors:  Elpis Mantadakis; Aggelos Tsalkidis; Maria Panopoulou; Spyridon Pagkalis; Gregory Tripsianis; Mathew E Falagas; Mathew Falagas; Sophia Kartali-Ktenidou; Athanassios Chatzimichael
Journal:  Int Urol Nephrol       Date:  2010-06-04       Impact factor: 2.370

3.  Risk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence study.

Authors:  Henry D Kalter; Robert H Gilman; Lawrence H Moulton; Anna R Cullotta; Lilia Cabrera; Billie Velapatiño
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

4.  Urinary tract infections in children < 2 years of age hospitalized in a tertiary medical center in Southern Israel: epidemiologic, imaging, and microbiologic characteristics of first episode in life.

Authors:  David Shaki; Gabriel Hodik; Siham Elamour; Raouf Nassar; Eyal Kristal; Ron Leibovitz; Amir Horev; Eugene Leibovitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-13       Impact factor: 3.267

5.  Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection.

Authors:  Elsa Roldan-Masedo; Talia Sainz; Almudena Gutierrez-Arroyo; Rosa Maria Gomez-Gil; Estefania Ballesteros; Luis Escosa; Fernando Baquero-Artigao; Ana Méndez-Echevarría
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-29       Impact factor: 3.267

6.  Five-year assessment of causative agents and antibiotic resistances in urinary tract infections.

Authors:  Bayram Çoban; Nesrin Ülkü; Halit Kaplan; Burhan Topal; Haluk Erdoğan; Esra Baskın
Journal:  Turk Pediatri Ars       Date:  2014-06-01

7.  A one-year prospective study on the antibiotic resistance of E. coli strains isolated in urinary specimens of children hospitalized at the University Pediatric Medical Center in Novi Sad, Serbia.

Authors:  E Jakovljević; K Ilić; Z Jelesić; G Konstantinidis
Journal:  Infection       Date:  2013-07-03       Impact factor: 3.553

Review 8.  Pathogens causing urinary tract infections in infants: a European overview by the ESCAPE study group.

Authors:  Irene Alberici; Aysun Karabay Bayazit; Dorota Drozdz; Sevinç Emre; Michel Fischbach; Jérôme Harambat; Augustina Jankauskiene; Mieczyslaw Litwin; Sevgi Mir; William Morello; Amira Peco-Antic; Peter Sallay; Lale Sever; Giacomo D Simonetti; Przemyslaw Szczesniak; Ana Teixeira; Enrico Vidal; Elke Wuehl; Otto Mehls; Lutz T Weber; Franz Schaefer; Giovanni Montini
Journal:  Eur J Pediatr       Date:  2014-11-28       Impact factor: 3.183

9.  Antibiotic sensitivity and resistance in children with urinary tract infection in Sanliurfa.

Authors:  Mahmut Abuhandan; Bülent Güzel; Yeşim Oymak; Halil Çiftçi
Journal:  Turk J Urol       Date:  2013-06

10.  Long-term resistance trends of uropathogens and association with antimicrobial prophylaxis.

Authors:  Maria Bitsori; Sofia Maraki; Emmanouil Galanakis
Journal:  Pediatr Nephrol       Date:  2013-12-21       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.